Investors / Israel / New Gate Capital
New Gate Capital
Venture capital · Jerusalem, Israel · Middle East and Africa
New Gate Capital is an investment firm based in Jerusalem. The page describes its focus as deep tech and strong teams, and states that it builds its work around people rather than projects or products.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsdeep tech
Your fit with New Gate Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNew Gate Capital lists 12 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (27%), AI & Machine Learning (20%) and Food & Agriculture (13%). 60% of its companies are based in Israel. It invests most often alongside Israel Innovation Authority, Ajinomoto Group Ventures and Backbone Ventures.
No funding round on record names New Gate Capital yet, so the figures come from its portfolio page.
Round figures show recent activity, not New Gate Capital's whole history. Rounds on record name 0 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 27% | 15% |
| AI & Machine Learning | 20% | 18% |
| Food & Agriculture | 13% | 3% |
| Industrial & Manufacturing | 13% | 7% |
| Cybersecurity | 7% | 4% |
| Climate & Energy | 7% | 1% |
| E-commerce & Marketplaces | 7% | 6% |
| Robotics & Hardware | 7% | 1% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Israel Innovation Authority | 2 |
| Ajinomoto Group Ventures | 1 |
| Backbone Ventures | 1 |
| Beyond Impact | 1 |
| Blue Horizon | 1 |
| Elah Fund | 1 |
| Emerge Ventures | 1 |
| Good Startup | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 41th | 27% in its largest sector |
| Reach | 58th | 3 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Israel Innovation Authority
Compare New Gate Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Cydome provides cybersecurity protection for maritime IT, OT, and communication devices, protocols, and operations | CybersecurityHealthcare & Biotech | Portfolio page | ||
| Freecurve Labs generates predictive molecular simulations from first principles to advance drug discovery, energy, and materials design | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Frenel develops and deploys AI-powered polarimetric thermal technology for next-generation electro-optical systems | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Korra provides a knowledge management tool that uses artificial intelligence to deliver precise answers and visual context to industrial teams | Industrial & Manufacturing | Portfolio page | ||
| Latica provides access to real-world patient data to accelerate innovations, improve care and lower costs for life sciences, medtech, and healthcare providers | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Naki converts food industry sludge into valuable materials for sustainable aviation fuel and biogas through a circular local process. | Food & AgricultureClimate & Energy | Portfolio page | ||
| NanoGhost develops a drug targeting platform from the cell membrane of mesenchymal stem cells | Healthcare & Biotech | Portfolio page | ||
| Neurobrave provides personalized mental healthcare to everyone, everywhere | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| SuperMeat produces cultured meat for human consumption | Food & Agriculture | Portfolio page | ||
| Xpand provides an off-the-shelf, unmanned store solution with automated picking and packing | E-commerce & MarketplacesRobotics & Hardware | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- newgate.capital
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get New Gate Capital's profile as data
Pull New Gate Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/newgate.capital
# also
GET /v1/firms/newgate.capital/portfolio
GET /v1/firms/newgate.capital/coinvestors
GET /v1/firms/newgate.capital/news